国产女人毛片一区二区| 欧洲精品无码一区二区三区在线播放| 亚洲精品国产综合麻豆成人久久大片91|亚洲精品无码抽插日韩|

<acronym id="kaa0k"></acronym>
<sup id="kaa0k"></sup>
<acronym id="kaa0k"><center id="kaa0k"></center></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"><center id="kaa0k"></center></acronym><acronym id="kaa0k"><small id="kaa0k"></small></acronym>

Welcome to Shanghai Kuanta Biomedicine science and technology Co., Ltd. official website!

PRODUCTS 

pharmaceutical intermediates

Pesticide intermediates

NEWS 

Exploring the development of biopharmaceuticals 7 passionate collisions among domestic and overseas academicians

【Industrial Opinion of China Pharmaceutical Network】 Recently, seven academicians from home and abroad have held keynote speeches and thematic discussions to discuss the opportunities and paths for development of biopharmaceutical investment under the background of Guangdong, Hong Kong, and Macao Bay Area, and to discuss the topics of the biomedical industry. In the future, we will actively provide advice and suggestions for the development of biomedical industry in Pingshan District.


  

★Academician of the U.S. National Academy of Engineering——Cato T.Laurencin (Gatto Laurentson)

American Academy of Engineering, Medical School, Academician of the Third World Academy of Sciences, and Foreign Academician of the Chinese Academy of Engineering. He received a doctorate in medicine from Harvard University in 1987 and is a world-renowned expert in biomaterial science and engineering, orthopaedic surgeon, and founder of regeneration engineering.

“My research is mainly focused on the fields of regenerative cells and stem cells, hoping to be able to reprogram and use living cells and allow the wounded tissue to restore its existing functions. This technology has won international medicine known as the Oscar of the US medical community. prize.

Whether it is translational medicine or regenerative engineering, it is a new way of thinking that connects basic medical research with clinical treatment. Shenzhen has shown great motivation in this respect. The government is investing heavily in biomedical research and strives to become The leader in the global field, and various advantages and conditions of Pingshan, let me finally make a choice. ”

★ Academician of Chinese Academy of Engineering – Ding Jian

An oncologist, graduated from the National University of Kyushu, Japan, with a doctorate in 1992. He was elected a member of the Chinese Academy of Engineering in 2009 and is currently the dean of the College of Pharmacy of the Chinese Academy of Sciences.

"To truly innovate, we must pay attention to basic research. Shenzhen has been at the forefront of the country in this regard. For Pingshan, we can start with building a government-supported public platform to continuously improve various functions, including biological medicine and Basic tests of technology, as well as some large scientific research equipment, will enable companies to meet their various R&D needs in Pingshan, which will also help attract companies to settle down and help companies grow.”

★ Academician of the Chinese Academy of Sciences——Yan Deyue

Polymer chemist, professor at Shanghai Jiaotong University, received a Ph.D. in natural science from Leuven Catholic University in Belgium in 2002 and was elected as a member of the Chinese Academy of Sciences in 2005.

"Chemical treatment is currently the most effective method of treating cancer, but it also has some shortcomings and problems, such as easy to induce drug resistance, strong side effects, etc. For this reason we proposed the concept of small molecule nanomedicine and carried out animal experiments. With certain achievements, the next step is to strive for clinical progress as quickly as possible, hoping to establish a platform for transformation in Pingshan.”

★ Chinese Academy of Sciences Academician Zhang Xuemin

In 1995, he received a doctorate degree from the Academy of Military Medical Sciences. He has been the chief scientist of the National Major Scientific Research Plan Project, and the Academic Leader of the "Tumor Biology" Innovative Research Group of the National Development Fund Committee.

"Now there are no particularly effective drugs for some major diseases. We can only try to solve them through innovation. In this regard, Shenzhen has an obvious advantage. As Shenzhen continues to increase institutional innovation and improve its innovation policy, it cannot do anything else in other areas. If you are slow, you can get to the clinic in Shenzhen.”

★ Academician of the US National Academy of Engineering——Sun Yongkui

He went to California Institute of Technology in 1983 and received his Ph.D. in chemistry. He was awarded the British Chemical Engineers Association AstraZeneca Green Chemistry and Engineering Excellence Award, and the US President's Green Chemistry Challenge Award. In 2016, he was elected to the American Academy of Engineering.

“The development of new drugs requires a variety of basic science support and an excellent R&D ecological environment. I think that the R&D environment can be solved by establishing a large platform to shorten the time period, accelerate the development of new drugs, and attract innovative talents. Let them focus on their own development."

★ Academician of British Royal Society of Chemistry——Zhao Xiaobin

Ph.D. in Medical Materials, Institute of Polymer Research, Nankai University, Ph.D., Bioengineering Department, Biomaterials and Artificial Instruments, University of Strathclyde, UK. He is currently a member of the British Royal Society of Chemistry and a Chartered Chemist.

"The development of Pingshan National Biopharmaceutical Base can learn from Australia's practice and actively introduce quality projects from outside. This will not only reduce costs, but also increase the success rate after entering the market, thus accelerating the growth of the base."

★ Academician of French National Academy of Science and Technology - Han Zhongchao

He is a professor and doctoral tutor of Nankai University School of Medicine, and is the head of the Institute of Hematology of the Chinese Academy of Medical Sciences and the Chinese Academy of Medical Sciences. He was elected as a foreign academician of the French Academy of Medical Sciences in 2006.

"Stem cells and immune cells have opened up a new therapeutic approach or therapeutic approach, opening up a whole new therapeutic effect for some diseases that are now difficult for medical treatment. Stem cell regenerative medicine plus immune cells will be a revolution in medicine. With very large clinical application prospects, Pingshan should pay attention to the introduction of such scientific institutions and enterprises."

Original title: The collision of passion thoughts explores the future of biomedical industry

Add: Room 1610, No. 2, Lane 789, Tianzhu Road, Jiading New City, Shanghai, China

Contact: Manager Feng   Mobile:+86-13916443339 

E-mail:feng1150@aliyun.com

Zip code:201810

Tel:+86-21-69580854 Fax:+86-21-51062356

URL:www.1423905857.com

Copyright(C)2018, Shanghai Kuanta Biomedical Technology Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 備案字號:滬ICP備18023014號

国产超碰人人做人人爱ⅴA|国产亚洲精品观看91在线|国产在线高清不卡免费视频|国产综合亚洲区在线观看| 狠狠躁狠狠躁东京热无码专区|最新国产欧美黄片大全|亚洲乱色熟女一区二区三区麻豆|天天躁日日躁狠狠躁出水| 成在人线av无码免观看vr|国产欧美在线视频播放|4480YY亚洲成年私人影院|天天躁日日躁狠狠躁大全| 国产精品毛片在线视频| 国产一区二区三区欧美日韩福利肛交| 99久久国产热精品无码免费专区|视频一区二区主播在线| 欧美亚洲国产另类在线观看|久久无码少妇一区二区三区|国产AV一区二区二三区冫|亚洲国产精品综合久久网络| 国内a级一级一片精品免费|婷婷亚洲国产小说区图片|女同久久另类99精品国产|久久久久久精品免费无码无| 国产片AV不卡在线观看|亚洲精品无码9久久久|久久无码精品亚洲日韩|91久久综合天天婷婷| 日韩精品在线三级免费观看|四虎国产精品永久免费视频|亚洲色偷偷色噜噜狠狠99|国产精品久久国产三级国|
<acronym id="kaa0k"></acronym>
<sup id="kaa0k"></sup>
<acronym id="kaa0k"><center id="kaa0k"></center></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"></acronym>
<acronym id="kaa0k"><center id="kaa0k"></center></acronym><acronym id="kaa0k"><small id="kaa0k"></small></acronym>